Sergey Yakushev studied protein biochemistry and molecular biology at Moscow State University and University of Zürich and obtained his PhD title in Integrative Molecular Medicine. During his postdoctoral research in prion disease at University Hospital Zürich he additionally finished the advanced studies in Pharmaceuticals at Swiss Federal Institute of Technology Zürich (ETH).

In 2015 he joined Microsynth AG, a leading company in nucleic acid synthesis & analysis. As head of the genetic analysis business unit his main focus is on developing, validating, and applying various analytical procedures, utilizing state-of-the-art technologies such as qPCR, ddPCR, NGS, and ONT-sequencing. Goal is to support biotech/pharma industry from R&D phase to the market authorization and routine release tests and to act as a reliable partner for the academy, enabling the collection of critical research data effectively and efficiently.